Executive record

Oliver Spandow

Director at NEPHROS INC

Follow
More
Challenge a Claim

Alpha ID: alpha:person:oliver-spandowVersion: public-0As of: 2026-09-28

Not yet claimed9 published Claims3 sources
  • Director

Key Claims

Biography

Mr. Spandow has served as Chief Financial Officer, Executive Vice President and board member of IDOC, LLC since December 2014. He spent 15 years with Johnson and Johnson in various roles including General Manager of J&J Vision Care in the UK and Ireland, and Vice President of Strategic Accounts and Finance. He was previously a Management Consultant with Price Waterhouse.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Dates not publishedExecutive title: Chief Financial Officer · Organization not publishedNEPH DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. NEPH DEF 14A director slate

    sec filing · Source published: Apr 30, 2025 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Audit, Compensation · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at IDOC, LLC · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Financial Officer · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  2. Open source

    sec proxy · Source published: Apr 30, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at NEPHROS INC · Claim reviewed: May 16, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of NEPHROS INC · Claim reviewed: May 16, 2026